Apollo Medical Holdings Inc (NASDAQ:AMEH) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 4,164,982 shares, a drop of 21.4% from the March 15th total of 5,586,570 shares. Based on an average daily volume of 363,997 shares, the days-to-cover ratio is currently 1.8 days. Currently, 2.4% of the shares of the company are sold short.

AEHR has been the subject of a number of recent analyst reports. BidaskClub upgraded shares of Apollo Medical Holdings from a “strong sell” rating to a “sell” rating in a research note on Friday, January 12th. Benchmark lowered shares of Apollo Medical Holdings from a “buy” rating to a “hold” rating in a research note on Monday, February 25th.

Get Apollo Medical Holdings alerts:

Apollo Medical Holdings (NASDAQ:AMEH) opened at $0.86 on Monday. The company has a debt-to-equity ratio of 9.06, a current ratio of 4.35 and a quick ratio of 4.35. Apollo Medical Holdings has a 52 week low of $0.82 and a 52 week high of $5.81.

COPYRIGHT VIOLATION NOTICE: “Apollo Medical Holdings Inc (NASDAQ:AMEH) Sees Significant Decrease in Short Interest” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at .

Several institutional investors have recently modified their holdings of AMEH. Wells Fargo & Company MN lifted its position in shares of Apollo Medical Holdings by 49.7% in the fourth quarter. Wells Fargo & Company MN now owns 79,299 shares of the company’s stock valued at $286,000 after purchasing an additional 27,498 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Apollo Medical Holdings by 74.3% in the third quarter. JPMorgan Chase & Co. now owns 229,643 shares of the company’s stock valued at $603,000 after purchasing an additional 97,333 shares during the period. Wells Fargo & Company MN lifted its position in shares of Apollo Medical Holdings by 0.7% in the third quarter. Wells Fargo & Company MN now owns 671,124 shares of the company’s stock valued at $1,520,000 after purchasing an additional 4,669 shares during the period. Northern Trust Corp lifted its position in shares of Apollo Medical Holdings by 77.0% in the second quarter. Northern Trust Corp now owns 1,156,837 shares of the company’s stock valued at $3,858,000 after purchasing an additional 491,568 shares during the period. Finally, Thrivent Financial For Lutherans lifted its position in shares of Apollo Medical Holdings by 58.2% in the second quarter. Thrivent Financial For Lutherans now owns 88,879 shares of the company’s stock valued at $159,000 after purchasing an additional 30,364 shares during the period. Hedge funds and other institutional investors own 16.31% of the company’s stock.

About Apollo Medical Holdings

Apollo Medical Holdings, Inc is engaged in the sales and distribution of device-based, non-invasive diagnostic and therapeutic non-invasive medical diagnostic tests. The Company is engaged in the sale and distribution of medical diagnostic products. The Company operates as a distributor of clinical laboratory test-related and the testing regimen-related products.

Receive News & Ratings for Apollo Medical Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical Holdings and related companies with MarketBeat.com's FREE daily email newsletter.